AbbVie Announces ABBV-951 Showed Improvement in Controlling Motor Fluctuations Compared to Oral Levodopa/Carbidopa Medication in Pivotal Phase 3 Trial in Patients with Advanced Parkinson's Disease Pharmaceutical Investing
HempFusion Launches Ingestible and Topical CBD Products into Major Arizona Grocer Cannabis Investing News
SHAREHOLDER ALERT: CLAIMSFILER REMINDS APPH, BMY, EAR, HEPS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Pharmaceutical Investing
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HNST Pharmaceutical Investing
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Pharmaceutical Investing
